The NNHPD has updated 18 monographs and was published on Décembre 19, 2025.
Monographs not in batches:
- Acne therapy
- Burdock – oral
- Chamomile German – oral
- Digestive enzymes (includes 11 additional enzymes previously captured by single ingredient monographs1; Fruit bromelain and Stem bromelain were also merged under a new entry for bromelain)
- Echinacea – Echinacea pallida
- Elder
- Feverfew (the maximum daily dose for migraine prevention was increased as per EMA 2020)
- Gingembre
- Linden
- Lungwort – oral
- Lysine
- Marshmallow – root
- Male genital desensitizers (the NPD ingredient Lidocaine was added)
- MSM
- N-Acetyl-L-cysteine
- Olive leaf
- Primary sunscreen
- Secondary sunscreen (the NPD ingredients Bemotrizinoland Bisoctrizole were added)
1The following single ingredient monographs will be removed from the Compendium of monographs since these enzymes were added to the Digestive enzymes monograph: alpha-amylase, alpha-galactosidase, cellulase, chymotrypsin, fruit bromelain/stem bromelain, fungal protease, lactase, lipase, pancreatic enzymes, papain and trypsin.
Modifications mineures apportées à des monographies déjà mises à jour
In addition, NNHPD has made minor revisions to the following 13 monographs:
- Black/white pepper – Piper nigrum
- Addition of ‘white’ to the title as this monograph includes white pepper as well;
- Clarification of the statements applicable to piperine;
- Addition of notes indicating the dose at which the statements are required, consistent with the Workout Supplements monograph.
- Caféine
- Adjustment to the Class II rules.
- Produits destinés à améliorer les fonctions cognitives
- Addition of the common name “Canadian ginseng” for Panax quinquefolius;
- French only: In Table 2.6 for Panax ginseng, the method of preparation was revised to remove “ethanolic” which was erroneously added since both ethanolic and aqueous extracts are acceptable.
- Echinacea purpurea (English only)
- The publication date was not updated, as only an error in the wording of the risk statements in English needed to be fixed to match the French version and the other Echinacea species monographs.
- Fish oil
- Addition of the note indicating that omega-3 potency can be added as additional information on the label.
- Garlic
- Addition of various types of enteric coated dosage forms.
- Joint health products
- The two medicinal ingredients ‘Fruit bromelain’ and ‘Stem bromelain’ were merged and represented as a single medicinal ingredient ‘Bromelain’ sourced from fruit and/or stem’;
- Calcium’s direction of use statement was divided into two statements (i.e., “Take with food” and “Take a few hours before or after taking other medications or health products”) to improve validation and avoid duplication of statements when combined with other medicinal ingredients;
- Adjustment of several references;
- French only: Revision of the proper names and source ingredient of MSM.
- Melatonin – oral
- Melatonin – sublingual
- Adjustment to the Class II and III rule.
- Panax quinquefolius
- Addition of the common name “Canadian ginseng”;
- Revision of the monograph title to ‘Panax quinquefolius’.
- Probiotics
- Addition of various types of enteric coated dosage forms.
- Saw palmetto
- Clarification of the medicinal ingredient supporting each claim (i.e., either Saw palmetto fruit or Saw palmetto liposterolic extract).
- Workout supplements
- Amino acids will be allowed as potency information for medicinal ingredients from Table 1 when sub-ingredients are available in the NHPID; several amino acids have been added to the NHPID; however, if amino acids for a specific medicinal ingredient are not available, a request to update the NHPID should be submitted to NNHPD;
- Addition of a combination rule for proteins and amino acids;
- Inclusion of Appendices with Workout Supplements and Multi-Vitamins/Minerals Supplements claims that are acceptable at Class II/III for products recommended for an occasional use only;
- Adjustment of an error in the reference section.
